Xiaoying Chen: Rethinking Thrombectomy in Large-Core Stroke – Insights from LASTE Analysis
Xiaoying Chen, Senior Research Fellow at The George Institute for Global Health, shared on LinkedIn about a recent article by Bertrand Lapergue et al, published in Stroke, adding:
”One of the hardest questions in acute stroke is how far we can safely extend reperfusion treatment in patients with very large established infarcts.
This secondary analysis from LASTE suggests that even patients with ASPECTS 0–2 should not be treated as a uniformly futile group, with signals for better outcomes and lower mortality after thrombectomy.
From my perspective, this is exactly where modern stroke trials need to go next: not broad over-simplifications of ‘large core’ stroke, but smarter subgroup learning that can identify where benefit persists, where bleeding risk rises, and how more precise treatment decisions can be made in real-world practice.”
Title: Endovascular Thrombectomy in Patients With Largest Baseline Infarcts (ASPECTS 0–2): An Ancillary Analysis of the LASTE Trial
Authors: Bertrand Lapergue, Caroline Arquizan, J.F. Albucher, Christophe Cognard, Hilde Henon, Nasreddine Nouri, Benjamin Gory, Sebastien Richard, Gauthier Marnat, Igor Sibon, Federico Di Maria, Mariam Annan, Grégoire Boulouis, Pere Cardona, Julien Labreuche, Vincent Costalat, Tudor Jovin
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 21, 2026, 11:45Heghine Khachatryan: Heavy Menstrual Bleeding in Women with Bleeding Disorders – Key Insights from WFH 2026
-
Apr 21, 2026, 11:40Emna HAMMAMI: Unpublished Dutch Data on IPFD Management Shared at EHA-SWG Meeting
-
Apr 21, 2026, 11:34Are Platelets Really Just Clotting Cells or Immune Orchestrators? – RPTH Journal
-
Apr 21, 2026, 11:22Leonard Valentino: The Importance of Early Diagnosis and Treatment of Hemophilia in Women and Girls – WFH2026
-
Apr 21, 2026, 11:20Shehab Mohamed: Thrombotic Complications in APL Are Not Rare and May Be Underrecognized
-
Apr 21, 2026, 09:29Wolfgang Miesbach: Can Gene Therapy Redefine Aging and Healthy Longevity?
-
Apr 21, 2026, 09:15Jim Hoffman: Targeting NETosis and Microclotting to Restore Immune and Hemostatic Balance
-
Apr 21, 2026, 09:00Amer Zeidan: Can Early Blood Count Changes Predict Imetelstat Response in Lower Risk MDS?
-
Apr 21, 2026, 08:49Giacomo Buso: Global Collaboration in Vascular Medicine at the XI ESVM Congress 2026